Revolutionizing Stroke Recovery: Unveiling the Promise of Stem Cell Therapy
DOI: https://doi.org/10.2147/dddt.s460998
IF: 4.3188
2024-03-30
Drug Design Development and Therapy
Abstract:Leonidas D Panos, 1, 2 Panagiotis Bargiotas, 2 Marcel Arnold, 1 Georgios Hadjigeorgiou, 2 Georgios D Panos 3, 4 1 Department of Neurology, Bern University Hospital Inselspital, Bern, Switzerland; 2 Department of Neurology, School of Medicine, University of Cyprus, Nicosia, Cyprus; 3 Department of Ophthalmology, Queen's Medical Centre, Nottingham University Hospitals (NUH), Nottingham, UK; 4 Division of Ophthalmology and Visual Sciences, School of Medicine, University of Nottingham, Nottingham, UK Correspondence: Leonidas D Panos, Department of Neurology, Bern University Hospital "Inselspital", Freiburgstrasse 16, Bern, 3010, Switzerland, Tel +41 31 632 70 00, Email Georgios D Panos, Department of Ophthalmology, Queen's Medical Centre, NUH, Derby Road, Lenton, Nottingham, NG7 2UH, UK, Tel +44 115 924 9924, Email Stem cells, renowned for their unique regenerative capabilities, present significant hope in treating stroke, a major cause of disability globally. This review offers a detailed analysis of stem cell applications in stroke (ischemic and hemorrhagic) recovery. It examines therapies based on autologous (patient-derived), allogeneic (donor-derived), and Granulocyte-Colony Stimulating Factor (G-CSF) based stem cells, focusing on cell types such as Mesenchymal Stem/Stromal Cells (MSCs), Bone Marrow Mononuclear Stem Cells (BMMSCs), and Neural Stem/Progenitor Cells (NSCs). The paper compiles clinical trial data to evaluate their effectiveness and safety and addresses the ethical concerns of these innovative treatments. By explaining the mechanisms of stem cell-induced neurological repair, this review underscores stem cells' potential in revolutionizing stroke rehabilitation and suggests avenues for future research. Keywords: stem cell therapy, stroke, brain hemorrhage, autologous stem cells transplantation, allogeneic stem cells transplantation, granulocyte-colony stimulating factor Stroke, often referred to as a cerebrovascular accident (CVA), stands as a formidable adversary in the realm of neurological disorders. This devastating event occurs when blood flow to a part of the brain is interrupted, leading to the impairment of vital functions controlled by that specific region. Classified into two main types—cerebral ischemia and cerebral hemorrhage—stroke imposes a significant burden on global health, being a leading cause of long-term disability and mortality. 1 It is the second leading cause of death and the third leading cause of death and disability combined worldwide. Between 1990 and 2019, there was a notable increase in stroke-related statistics, with a 70% rise in incident strokes, a 43% increase in deaths from stroke, and a 143% increase in disability-adjusted life years (DALYs). 2 Despite advances in acute stroke management, including thrombolytic therapy and thrombectomy, the quest for effective treatments to mitigate the long-term consequences of stroke remains paramount. Recent advancements in neurorestorative therapies, such as neurostimulation and cell transplantation, are pivotal in stroke recovery. Neurostimulation techniques, including cortical and cerebellar stimulation, vagal stimulation, and optogenetics, enhance synaptic plasticity and reorganize neural circuitry. Cell transplantation involves both endogenous strategies to stimulate neural stem cells and exogenous therapies to replace damaged neurons. These multidimensional mechanisms aim to leverage the brain's inherent plasticity, promoting repair and reorganization of neural networks disrupted by stroke. 3 In this review, we delve into the evolving landscape of stem cell therapy in stroke.The first instance of stem cell therapy for stroke patients involved the use of neuroterocarcinoma cells that were transformed into postmitotic neurons. This pioneering approach was conducted by Kondziolka et al in 1998, marking a significant milestone in the field. 4 The study provided preliminary data on the safety, feasibility, and tolerability of stem cell therapy in humans, laying the groundwork for subsequent research in this area. Preclinical research on stem cell therapy for stroke has highlighted both the therapeutic potential and the challenges of this approach. Boltze et al emphasize the use of large animal models (LAMs) due to their gyrencephalic brains, which more accurately mimic human brain anatomy and are suitable for advanced imaging techniques. 5 They note the challenges and benefits of working with LAMs, including their potential for more realistic testing of cell delivery techniques and the exploration of stroke sequelae like cognitive impairment. Stem cells have been implicated in promoting brain repair mechanisms such as angiogenesis, neurogenesis, and gliog -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal